News

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of February 23, 2020.

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

The FDA has approved an application for the first generic of Daraprim (pyrimethamine) tablets for the treatment of toxoplasmosis when used with a sulfonamide.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Preliminary evidence indicates no direct evidence for intrauterine transmission of the SARS-CoV-2 virus from pregnant women with COVID-19 to their infants.

While locally-acquired Chagas disease is rare in the United States, the testing of a blood donation sample led to what is likely the first documented case of the disease in Missouri.

As February comes to an end, we’re looking back at important infectious disease news from the past month.

In addition to meeting its primary endpoint, cefepime-enmetazobactam displayed superiority over piperacillin-tazobactam alongside a comparable safety profile.

Antimicrobial stewardship experts are sharing their favorite tips and identifying myths about antibiotics.

New research pinpoints some of the factors involved in HIV reemergence after cessation of antiretroviral therapy, as well as possible ways to stop the process.

Health officials are investigation an outbreak of E coli in 5 states with a suspected link to clover sprouts served at Jimmy John’s restaurants.

Using enteral vancomycin for C diff prophylaxis may be the key to reducing morbidity and improving outcomes in pediatric and young adult recipients of HSCT.

In models of air transportation networks during the early stages of an outbreak, disease spread could be reduced by up to 38% with improved hand washing at 10 major airports.

Influenza-associated hospitalization rates among children and young adults are considered higher than recent flu seasons.

What can we learn from those who met PUI criteria?

The CDC has confirmed an infection with the virus that causes COVID-19 in California in a person who reportedly did not have relevant travel history or exposure to another known patient with COVID-19

RESTORE-IMI 1 showed a safety difference IMI-REL and IMI+CST when it comes to nephrotoxicity. The team behind a new retrospective study has applied acute kidney injury assessments to the results.

The US Food and Drug Administration has sent the sandwich chain a warning letter over citing involvement in several outbreaks of Salmonella and Escherichia coli over the past 7 years.

Most US cases of dengue came from patients with a history of travel, according to a new report.

An article in Open Forum Infectious Diseases includes advice from and support for fellowship program directors.

Among a cohort of 9 pregnant women who developed COVID-19 pneumonia, there was no evidence of vertical transmission to infants.

Biofilms are an emerging clinical problem despite the fact that most clinicians don’t even think of biofilms when managing infections.

Clinicians accustomed to HIPAA guidelines may not be aware of changes in confidentiality when they make contact with school health care services.

The randomized controlled trial will assess the activity of the antiviral remdesivir among hospitalized adults at the University of Nebraska Medical Center.

A new study looks at how vancomycin-resistant enterococci spread through contact between patients and health care workers.

A small but significant percentage of Americans believe common misconceptions about vaccines, and that misinformation was associated with social media use and lower trust of medical experts, a new study found.

Based on data from 4112 children and adults, vaccine effectiveness was estimated to be 37% against influenza A and 50% against influenza B viruses.

Progression to lower respiratory tract disease was associated with higher total antibiotic-days, use of antibiotics with broad anaerobic activity, and use of cephalosporins with limited anaerobic activity.

Patients who had OUD and sepsis were found to be younger and healthier than patients without OUD.

The US Food and Drug Administration approved the first adjuvanted quadrivalent influenza vaccine for adults 65 years and older.